Hodgkin's lymphoma in the young child

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Primarily a disease of adults, Hodgkin's lymphoma (HL) contributes significantly to pediatric malignant diseases, particularly in developing countries where the incidence is higher. The treatment has evolved and now most patients are treated with chemotherapy; the optimal use additional radiation therapy (XRT) is being questioned, and it is likely that XRT will be reserved for a subset of higher risk patients. Patients with advanced disease have lower outcomes, which have improved with chemotherapy intensification. This has the potential for increasing acute and long-term toxicity. Treatment strategies for HL should be risk and response stratified, aiming at reduction of toxic effects.

Original languageEnglish
Pages (from-to)163-167
Number of pages5
JournalTransfusion and Apheresis Science
Issue number2
Publication statusPublished - Apr 2010
Externally publishedYes


  • Chemotherapy
  • Hodgkin's Lymphoma
  • Outcome
  • Pediatric
  • Radiation therapy


Dive into the research topics of 'Hodgkin's lymphoma in the young child'. Together they form a unique fingerprint.

Cite this